
Elevara Medicines names biotech veteran Mai-Britt Zocca as new CEO to advance rheumatoid arthritis drug ELV001.
Elevara Medicines appointed Dr. Mai-Britt Zocca as CEO, succeeding founder Emma Tinsley who will remain on the board. Dr. Zocca brings extensive biotech leadership experience, having led Nasdaq-listed IO Biotech through advanced clinical trials. Elev...


